Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
What it is: A 15-amino-acid synthetic peptide sharing the BPC-157 sequence (GEPPPGKPADDAGLV), marketed with an arginine salt counterion rather than an acetate salt
Retatrutide is being developed by Eli Lilly and Company , the same pharmaceutical company behind Mounjaro (tirzepatide) and the oral GLP-1 weight loss medicine Foundayo (orforglipron)
Seniors preventing muscle/cognitive decline: Supports sarcopenia resistance
It means you can have a productive, evidence-based conversation with your doctor
US$ 22.14
US$ 29.64
US$ 21.24
